Allergy Immunotherapies Market Share, Size, and Outlook by 2031
Allergy Immunotherapies Market: Strategic Insights
Allergy Immunotherapies Market
-
CAGR (2023 - 2031)9.0% -
Market Size 2021
US$ 2.16 Billion -
Market Size 2031
US$ 5.11 Billion
Market Dynamics
GROWTH DRIVERS
- Growing Prevalence of Allergic Disorders
FUTURE TRENDS
- Presence of Strong Product Pipeline
OPPORTUNITIES
- Increasing FDA Approvals for Drugs
Key Players
- ALK Abell A S
- Nestl Health Science
- LETIPharma
- Stallergenes Greer
- HAL Allergy B V
- Johnson and Johnson Services Inc
- Anergis
- DBV Technologies
- Dermapharm Holding
- Allergy Therapeutics
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Treatment - Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Type - Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
Distribution Channel - Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Get Free Sample For